Additional Therapeutic Applications

Navitor’s discovery efforts, both proprietary and partnered, will leverage the potential to selectively modulate mTORC1 activity to address diseases that are caused by dysfunctional mTOR activity.

 

Additional Therapeutic Applications

Back to Top